Advances in hepatitis B therapeutics

Despite the availability of both effective preventive vaccines and oral antivirals, over 250 million people are chronically infected with the hepatitis B virus (HBV). Globally, chronic hepatitis B is the leading cause of hepatocellular carcinoma, which represents the third cause of cancer mortality,...

Descripción completa

Detalles Bibliográficos
Autores principales: Soriano, Vicente, Barreiro, Pablo, Cachay, Edward, Kottilil, Shyamasundaran, Fernandez-Montero, José V., de Mendoza, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570774/
https://www.ncbi.nlm.nih.gov/pubmed/33117536
http://dx.doi.org/10.1177/2049936120965027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570774/
https://www.ncbi.nlm.nih.gov/pubmed/33117536
http://dx.doi.org/10.1177/2049936120965027

Ejemplares similares